Financing Health in Africa - Le blog
  • Home
  • Bloggers
  • Collaborative projects
  • Join our COPs
  • Resources
  • About Us
  • Contact Us

We just learned a whole lot more about RBF

9/28/2016

2 Commentaires

 
Picture
Ellen van de Poel

On September 18th- 23rd, the World Bank held its Results and Impact Evaluation workshop for Results-Based Financing in Harare, Zimbabwe. Ellen Van de Poel from the Institute of Health Policy and Management, Erasmus University Rotterdam summarizes some of her take home messages.
​

 
Spending a week in Harare for the Annual Results and Impact Evaluation workshop for Results-Based Financing turned out to be quite refreshing and stimulating. I was impressed by the enormous amount of work that has been done, both from the implementation and research side. Teams from 23 countries have moved forward with implementing some form of RBF and really interact with and learn from each other.
 
Better incentivizing quality of care, expanding RBF to community health workers and reducing the cost of verification were some of the hot topics of discussion during the week. I was even more impressed by the genuine interest from policy makers in the impact evaluation (IE) results. These studies, and the wealth of data that has been and will be collected, will undoubtedly contribute to the evidence base on whether, how and why RBF works and what are the most important components of such programs.  Having so many relatively similar impact evaluations offers possibilities for generalization that are much more difficult to obtain from a literature review. We should make the most of this opportunity.

 
Feedback from an afternoon parallel session
 
On Wednesday 21st, together with a group of researchers, we debated on some of the issues IE researchers are currently struggling with. Here is a list of key points of interest.

  • When do we consider a pilot to be successful? Most schemes incentivize many health services, and therefore evaluation studies look at impact on many indicators. Some find effects on ANC, others on institutional deliveries or on vaccinations. Given the variation in scheme design and policy context, it’s difficult to get to a standard evaluation framework. But it might be useful to formulate some clear main hypotheses, perhaps based on the relative pricing of services, the coverage rate at the baseline and on policy priorities, and have these guide the research, rather than looking at all service indicators available in the data and getting enthusiastic when at least one of such effects is statistically significant.

  • How to generalize findings across countries and schemes? We learned that the World Bank is planning to conduct a meta-analysis of all the IE results. It will help drawing some overall conclusions on the barriers and enablers for successful implementation of RBF. Levels of integration, credibility of the link between payment and results, power of the incentives, autonomy of the provider, capacity to hire and fire, and baseline levels are likely important aspects to consider in such a meta-analysis.

  • What time horizon should we consider in RBF impact evaluations? Most of the IE studies have a two-three years’ time horizon. Participants wondered whether this is not too short to do justice to the real impact as pilots typically take about a year to be fully operational.

  • How to explain some of the effects? In some countries, the research design allowed to test different components of the theory of change of PBF (transfer of funds directly to facilities, autonomy, the incentive contract…). In Zambia, and to some extent in Cameroon, IE results suggest that providing additional budget with autonomy to facilities can be equally effective, and therefore more cost-effective, than the RBF programs with incentives. We’re not quite sure yet why this is the case. Are we really measuring the effect of additional budget, or are control areas also indirectly affected by the incentive structure in the treatment areas?

  • How to increase the policy relevance of further IE evidence? Robust Randomized Controlled Trials (RCT) designs are important to establish causal impact on main outcomes. This evidence was/is urgently called for, especially given the relatively high implementation costs of RBF programs. But as we move forward, the implementation questions that countries are struggling with do not easily lend themselves for RCT type of designs. So we’ll need to think more about how to use operational or administrative data to provide (quick) answers to these questions.
 
Way forward
 
Perhaps the most important thing I learned at this workshop is that the relevant debate is really not around whether we should continue with RBF or not. The core ideas of RBF (a provider payment reform coupled with improved accountability and autonomy) are indeed essential to health systems strengthening everywhere. The relevant question is whether the RBF vehicle as it is currently used is the most efficient one, and to which extent it needs to be updated or supplemented with demand side incentives. With this energetic group of people on board in all of these projects, I’m hopeful we’ll get answers to many of these questions soon. 

2 Commentaires
Manga Danlami Haruna link
9/28/2016 09:22:35 pm

What a great work being under taken by our tram of experience expect on result based financing. Such conference resolution should urgently put to fill implementation.

Répondre
Godelieve van Heteren link
9/29/2016 09:59:21 am

Great succinct summary of some of the key evaluation debates regarding RBF impact. Thanks Ellen!

Répondre



Laisser un réponse.


    Our websites

    Photo
    Photo
    Photo

    We like them...

    SINA-Health
    International Health Policies
    CGD

    Archives

    Septembre 2019
    Juin 2019
    Avril 2019
    Mars 2019
    Mai 2018
    Avril 2018
    Mars 2018
    Février 2018
    Janvier 2018
    Décembre 2017
    Octobre 2017
    Septembre 2017
    Août 2017
    Juillet 2017
    Juin 2017
    Mai 2017
    Avril 2017
    Mars 2017
    Février 2017
    Janvier 2017
    Décembre 2016
    Novembre 2016
    Octobre 2016
    Septembre 2016
    Août 2016
    Juillet 2016
    Avril 2016
    Mars 2016
    Février 2016
    Janvier 2016
    Décembre 2015
    Novembre 2015
    Octobre 2015
    Septembre 2015
    Août 2015
    Juillet 2015
    Juin 2015
    Mai 2015
    Avril 2015
    Mars 2015
    Février 2015
    Janvier 2015
    Décembre 2014
    Octobre 2014
    Septembre 2014
    Juillet 2014
    Juin 2014
    Mai 2014
    Avril 2014
    Mars 2014
    Février 2014
    Janvier 2014
    Décembre 2013
    Novembre 2013
    Octobre 2013
    Septembre 2013
    Août 2013
    Juillet 2013
    Juin 2013
    Mai 2013
    Avril 2013
    Mars 2013
    Février 2013
    Janvier 2013
    Décembre 2012
    Novembre 2012
    Octobre 2012
    Septembre 2012
    Août 2012
    Juillet 2012
    Juin 2012
    Mai 2012
    Avril 2012
    Mars 2012
    Février 2012
    Janvier 2012
    Décembre 2011
    Novembre 2011
    Octobre 2011

    Tags

    Tout
    2012
    Accountability
    Aid
    Alex Ergo
    Assurance Maladie
    Bad
    Bamako Initiative
    Bénin
    Bruno Meessen
    Burkina Faso
    Burundi
    Civil Society
    Communauteacute-de-pratique
    Communauté De Pratique
    Community Of Practice
    Community Participation
    Conference
    Cop
    Course
    Couverture Universelle
    CSU
    Déclaration De Harare
    Divine Ikenwilo
    Dr Congo
    économie Politique
    élections
    équité
    Equity
    Fbp
    Financement Basé Sur Les Résultats
    Financement Public
    Fragilité
    Fragility
    Free Health Care
    Global Fund
    Global Health Governance
    Gratuité
    Gratuité
    Health Equity Fund
    Health Insurance
    ICT
    Identification Des Pauvres
    Isidore Sieleunou
    Jb Falisse
    Jurrien Toonen
    Kenya
    Knowledge-management
    Kouamé
    Leadership
    Mali
    Management
    Maroc
    Maternal And Child Health
    Médicaments
    Mise En Oeuvre
    Mutuelle
    National Health Accounts
    Ngo
    Niger
    Omd
    OMS
    Parlement
    Participation Communautaire
    Pba
    Pbf
    Plaidoyer
    Policy Process
    Politique
    Politique De Gratuité
    Politique De Gratuité
    Post Conflit
    Post-conflit
    Private Sector
    Processus Politique
    Qualité Des Soins
    Qualité Des Soins
    Quality Of Care
    Recherche
    Redevabilité
    Reform
    Réforme
    Research
    Results Based Financing
    Rwanda
    Santé Maternelle
    Secteur Privé
    Sénégal
    Société Civile
    Uganda
    Universal Health Coverage
    User Fee Removal
    Voeux 2012
    Voucher
    WHO

Powered by Create your own unique website with customizable templates.